Novo Launches Citizen Petition to Block Compounded Victoza
2 days ago · Novo Nordisk last month filed a Citizen Petition with the FDA asking the federal agency to exclude its type 2 diabetes injection Victoza (liraglutide) from a proposed list of drugs eligible for compounding.. The petition comes after the industry group Outsourcing Facilities Association (OFA), which represents FDA-registered compounding pharmacies, nominated liraglutide to the 503B Bulks List ...
Novo asks FDA to restrict Victoza compounding amid GLP-1 …
5 days ago · As concerns around knockoffs of newer GLP-1 drugs like Ozempic and Wegovy take center stage, Novo Nordisk’s efforts to ward off competition against its aging diabetes blockbuster Victoza have been
Novo Nordisk Pushes FDA To Exclude Compounding For Its Early …
2 days ago · In December, Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) submitted a Citizen Petition to the FDA requesting the exclusion of liraglutide from the 503B Bulks List, a registry of ...
Novo Nordisk asks FDA not to allow GLP-1 compounding
2 days ago · The latest attempt focuses on liraglutide, an older, once-daily injectable product in Novo Nordisk's GLP-1 agonist franchise sold as Victoza and Xultophy for diabetes and Saxenda for obesity.
Novo Nordisk seeks to block compounded Victoza - MSN
Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of drugs that are allowed to be compounded. In a Citizen Petition posted on ...
FDA approves generic version of Novo Nordisk's GLP-1 diabetes drug Victoza
Dec 23, 2024 · The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country.
Novo Nordisk discontinues type 2 diabetes treatment Victoza
Oct 22, 2024 · Victoza (liraglutide) pre-filled injection pens, used in the treatment of type 2 diabetes mellitus, have been out of stock in the UK since August 2023.
Manufacturer confirms discontinuation of type 2 diabetes mellitus ...
Oct 21, 2024 · Novo Nordisk has confirmed that its Victoza (liraglutide) 6mg/mL pre-filled injection pens have been discontinued.
Ozempic shortage makes Novo Nordisk reduce supply of Victoza …
Nov 22, 2023 · Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug...
FDA approves Hikma's generic version of Novo's diabetes drug Victoza
Dec 24, 2024 · The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the...
- Some results have been removed